THBD (also known as thrombomodulin, fetomodulin, and CD141) is not only a thrombin receptor but also an oncodevelopmental antigen, which is considered to modulate cancer cell behaviour related to anticoagulant activity45. This evidence concerns the gene THBD and cancer.